BioCryst Pharmaceuticals (BCRX) Fails to deliver data

Key failure to deliver metrics for BioCryst Pharmaceuticals :

• Last SEC data release: 2024-12-31
• Last 15 days FTD volume: £0.03 M
• Last 3 months FTD volume: £0.4 M
• Last year FTD volume: £0.4 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioCryst Pharmaceuticals (BCRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioCryst Pharmaceuticals (BCRX) - since 2013

BioCryst Pharmaceuticals (BCRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Repligen RGEN	£2.12 M	£34.35 M	🇺🇸 USA
Sarepta Therapeutics SRPT	£9.51 M	£41.97 M	🇺🇸 USA
NanoViricides NNVC	£2.28 M	£4.93 M	🇺🇸 USA
Novavax NVAX	£25.9 M	£0.14 B	🇺🇸 USA
Gilead Sciences GILD	£36.09 M	£0.14 B	🇺🇸 USA
Celldex Therapeutics CLDX	£1.13 M	£5.65 M	🇺🇸 USA
GlaxoSmithKline GSK	£96.61 M	£0.14 B	🇬🇧 UK
Emergent BioSolutions EBS	£1.39 M	£5.95 M	🇺🇸 USA
Cel-Sci CVM	£0.69 M	£2.93 M	🇺🇸 USA